FGL
preclinicalAlso known as: FG Loop peptide, FGL(L)
**Mechanism of Action** FGL (FG Loop peptide) is a synthetic peptide derived from the neural cell adhesion molecule (NCAM) that mimics the homophilic binding interface of NCAM’s second fibronectin type III module. It selectively activates fibroblast growth factor receptor 1 (FGFR1) via the FG loop region, triggering downstream signaling cascades (e.g., MAPK/ERK and PLCγ pathways). This activation promotes neurite outgrowth, synaptogenesis, and long-term potentiation (LTP), thereby enhancing synaptic plasticity and memory consolidation in preclinical models. **Key Research Findings** Preclinical studies demonstrate that FGL improves spatial learning and memory in rodent models of aging, Alzheimer’s disease, and traumatic brain injury. For example, systemic or intracerebroventricular administration of FGL reverses cognitive deficits in APP/PS1 transgenic mice and enhances hippocampal LTP. The peptide also reduces amyloid-beta plaque burden and neuroinflammation in some models. Notably, FGL’s effects are dose-dependent and require intact FGFR1 signaling, as FGFR1 antagonists block its cognitive benefits. **Clinical Relevance** FGL remains in preclinical development, with no human trials reported. Its potential applications include age-related cognitive decline, Alzheimer’s disease, and other conditions involving synaptic dysfunction. Challenges include optimizing blood-brain barrier penetration and minimizing off-target FGFR activation (e.g., mitogenic effects). Further validation in higher-order species and long-term safety studies are needed before clinical translation. For research purposes only — not medical advice.
Key data
Research & studies
Comparable overall survival across chemotherapy, chemoimmunotherapy, and immunotherapy without unexpected adverse events.; Distinct NSCLC-like (KEAP1, KRAS, STK11 mutations) and SCLC-like (RB1, TP53 mutations) LCNEC subtypes identified, with 80% aligning with SCLC transcriptional profiles.; Elevated FGL-1 and SPINK1 expression in NSCLC-like LCNECs, and higher DLL3 levels in SCLC-like LCNECs.; Fewer tumor-infiltrating lymphocytes in LCNECs compared to other lung cancers.
CAF activation trajectory is divided into three states with distinct cell interactions and immunotherapy prognosis associations.; Minor CAF components can originate from other TME components like endothelia and macrophages.; Endothelial-to-mesenchymal transition CAFs are ubiquitously present and may interact with SPP1+ tumor-associated macrophages, impacting survival stratification.; A browser for the integrated pan-cancer single-cell data is available online.
FGL significantly enhanced NSC proliferation in vitro, with maximal effect at 10 μg/ml.; FGL induced oligodendroglial differentiation, while NCAM promoted neurogenesis.; In vivo, FGL increased proliferative activity of NSC in the subventricular zone.; Non-invasive PET imaging confirmed FGL-induced mobilization of NSC from the subventricular zone and hippocampus.
Frequently asked questions
What is FGL?
**Mechanism of Action** FGL (FG Loop peptide) is a synthetic peptide derived from the neural cell adhesion molecule (NCAM) that mimics the homophilic binding interface of NCAM’s second fibronectin type III module. It selectively activates fibroblast growth factor receptor 1 (FGFR1) via the FG loop region, triggering do
How does FGL work?
NCAM-derived FG-loop peptide that activates FGFR1 to enhance synaptic plasticity and memory in animal models.
What is the research status of FGL?
FGL is currently classified as preclinical, with 257 research references on record. This is for research purposes only and is not medical advice.
Related peptides
CNTF-derived peptidergic compound that promotes neurogenesis and reduces tau pathology in preclinical Alzheimer's models.
33-aa hypothalamic neuropeptide acting on OX1/OX2 receptors to promote wakefulness and arousal.
Porcine brain-derived peptide preparation with neurotrophic-factor-like activity studied in stroke, TBI, and dementia.
Ligand for NPSR1 . Binds to its receptor with nanomolar affinity and initiates a G /GNAQ-dependent phospholipase C-activating signaling pathway. This results in Ca mobilization from intracellular stores and increased int…
May function as an output molecule from the suprachiasmatic nucleus that transmits behavioral circadian rhythm.
ACTH(4-10)-derived heptapeptide that elevates BDNF and modulates the melanocortin system; used clinically in Russia for stroke and cognition.
Build on FGL data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key